文献速递结核与非结核分枝杆菌

血液转录组特征诊断结核病的临床实践前瞻性多中心队列研究

Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study.
PubMed 文献 · Lancet Infect Dis · 2021-01-25

VANTDET研究嵌套于英格兰前瞻性多中心队列,纳入628例临床疑似结核的成人,评估6个队列衍生和3个已发表转录组特征的诊断准确性。表现最佳的新特征识别全部活动性结核的AUC-ROC为0·87(95%CI 0·81-0·92),敏感度77%、特异度84%;最佳已发表特征AUC-ROC为0·83。所有特征均未达到WHO对非痰诊断试验的配对敏感度与特异度目标。

要点

  • 所有转录组特征均未达到WHO非痰诊断试验的敏感度与特异度目标。
  • 最佳新特征识别全部活动性结核的AUC-ROC为0·87,敏感度77%、特异度84%。
  • 在高度 probable 结核患者中最佳新特征AUC-ROC为0·86,敏感度77%、特异度77%。

核心结论

  • 在低发病率地区常规实践的临床代表性队列中,转录组特征对结核病诊断准确性不足,临床效用有限。

主要发现

  • 628例中212例(34%)为培养确诊结核,89例(14%)为高度 probable 结核,327例(52%)排除结核。
  • 表现最佳的新特征识别全部活动性结核的AUC-ROC为0·87(95%CI 0·81-0·92),敏感度77%(66-87)、特异度84%(74-91)。
  • 最佳已发表特征识别全部活动性结核的AUC-ROC为0·83(95%CI 0·80-0·86),敏感度78%(73-83)、特异度76%(70-80)。
  • 检测高度 probable 结核时最佳新特征AUC-ROC为0·86(95%CI 0·71-0·95),敏感度77%(56-94%)、特异度77%(57-95%)。
  • 所有相关队列衍生或已发表特征均未达到WHO定义的非痰诊断试验配对敏感度与特异度目标。

关键数值与推荐

  • WHO非痰诊断试验的配对敏感度与特异度目标未被任何评估特征达到(原文未给出具体阈值)。

临床怎么用

  • 转录组特征不宜用于临床疑似结核的诊断评估,包括高度 probable 结核患者。

局限性

  • 研究在低发病率地区开展,结论外推至高发病率或不同人群时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blood transcriptomic signatures for diagnosis of tuberculosis have shown promise in case-control studies, but none have been prospectively designed or validated in adults presenting with the full clinical spectrum of suspected tuberculosis, including extrapulmonary tuberculosis and common differential diagnoses that clinically resemble tuberculosis. We aimed to evaluate the diagnostic accuracy of transcriptomic signatures in patients presenting with clinically suspected tuberculosis in routine practice. METHODS: The Validation of New Technologies for Diagnostic Evaluation of Tuberculosis (VANTDET) study was nested within a prospective, multicentre cohort study in secondary care in England (IDEA 11/H0722/8). Patients (aged ≥16 years) suspected of having tuberculosis in the routine clinical inpatient and outpatient setting were recruited at ten National Health Service hospitals in England for IDEA and were included in VANTDET if they provided consent for genomic analysis. Patients had whole blood taken for microarray analysis to measure abundance of transcripts and were followed up for 6-12 months to determine final diagnoses on the basis of predefined diagnostic criteria. The diagnostic accuracy of six signatures derived from the cohort and three previously published transcriptomic signatures with potentially high diagnostic performance were assessed by calculating area under the receiver-operating characteristic curves (AUC-ROCs), sensitivities, and specificities. FINDINGS: Between Nov 25, 2011, and Dec 31, 2013, 1162 participants were enrolled. 628 participants (aged ≥16 years) were included in the analysis, of whom 212 (34%) had culture-confirmed tuberculosis, 89 (14%) had highly probable tuberculosis, and 327 (52%) had tuberculosis excluded. The novel signature with highest performance for identifying all active tuberculosis gave an AUC-ROC of 0·87 (95% CI 0·81-0·92), sensitivity of 77% (66-87), and specificity of 84% (74-91). The best-performing published signature gave an AUC-ROC of 0·83 (0·80-0·86), sensitivity of 78% (73-83), and specificity of 76% (70-80). For detecting highly probable tuberculosis, the best novel signature yielded results of 0·86 (0·71-0·95), 77% (56-94%), and 77% (57-95%). None of the relevant cohort-derived or previously published signatures achieved the WHO-defined targets of paired sensitivity and specificity for a non-sputum-based diagnostic test. INTERPRETATION: In a clinically representative cohort in routine practice in a low-incidence setting, transcriptomic signatures did not have adequate accuracy for diagnosis of tuberculosis, including in patients with highly probable tuberculosis where the unmet need is greatest. These findings suggest that transcriptomic signatures have little clinical utility for diagnostic assessment of suspected tuberculosis. FUNDING: National Institute for Health Research.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hoang LT, Jain P, Pillay TD, et al. Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study. Lancet Infect Dis. 2021. PMID: 33508221. doi:10.1016/S1473-3099(20)30928-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。